目的:探讨小儿支原体肺炎患儿采用中药方剂联合阿奇霉素抗支原体感染临床疗效.方法:本组84例支原体肺炎患儿按入院先后顺序随机分为观察组和对照组各42例.对照组患者用阿奇霉素静脉滴注治疗,观察组在此基础增加中药方剂内服治疗.结果:治疗后观察组患者临床总有效率(92.86％)显著高于对照组(71.43％),差异有统计学意义;观察组治疗后止咳平均时间、气喘消失平均时间、湿罗音消失平均时间、退热时间及治疗时间均低于对照组患者;观察组患者治疗后的免疫功能指标包括IL-6、TNF-α水平值低于对照组;观察组患者不良反应显著低于对照组患者.结论:小儿支原体肺炎患儿采用中药方剂联合阿奇霉素抗支原体感染临床疗效显著,不良反应较轻,具有重要的临床研究价值.%Objective:To investigate anti-mycoplasma infection clinical efficacy of traditional Chinese medicine in children with Mycoplasma pneumonia combined with azithromycin.Methods:84 children with mycoplasma pneumonia were randomly divided into the observation group and the control group according to the order of admission,with 42 patients in each group.The patients in the control group were treated with azithromycin intravenous drip,and the observation group was treated with Chinese medicine orally.Results:After treatment,the total effective rate of observation group was significantly higher than the control group,and there was statistical difference;the patients in the observation group,the average time of asthma cough disappeared time and the average wet rates disappearance time,average cooling time and treatment time were lower than the control group,to observe the immune;function groups of patients after treatment,including IL-6,TNF-levels were lower than the control group;adverse reactions in the observation group were significantly lower than the control group.Conclusions Children with Mycoplasma pneumonia combined with traditional Chinese medicine prescription anti-mycoplasma infection azithromycin has significant clinical efficacy,adverse reactions lighter with important clinical research value.
展开▼
